BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


July Archive 2005 - have your press release here?

SR Pharma announces £10m of new funding following a successful fundraising

OXFORD BIOMEDICA SUCCESSFULLY COMPLETES STAGE ONE OF THE PHASE II TRIAL WITH METXIA IN PANCREATIC CANCER

OXFORD BIOMEDICA IS AWARDED GRANT FOR MONUDIN® FROM THE MOTOR NEURONE DISEASE ASSOCIATION

POWDERMED MANUFACTURES A VACCINE AGAINST H5N1 (AVIAN INFLUENZA) FOR CLINICAL DEVELOPMENT

Microm Microtech France in drive for growth after management buy-out

Inpharmatica Announces Chematica(TM) Collaboration with Tibotec Pharmaceuticals Ltd.

New Report Examines Biotech Giant Amgen’s Success and Future Direction

Brain cancer: glioblastoma incidence to pass 18,000 cases by 2015

Cancer therapy: clinical trials to trigger antihormonals market shift

Scientists advance understanding of the role of a key brain protein in autism

Following Inspection by UK Regulators, Cobra's Manufacturing Authorisation is extended

Uncertainty reigns as biotech patents remain unharmonised

Discover and understand unmet needs in the ADHD market

A Tip for Better Pipetting: P2i surface enhancements for pipette tips reduce retention and open up other functional capabilities.

MIP wins pyrethroid residue detection contract with US EPA

Syngene's GeneGenius at Leading UK University Is Helping Accurately Detect Mutations in Microbial DNA

Peakdale establishes in-house computational chemistry capabilities

Blue Membranes closes its 2nd round financing after the technology buy-out in late 2003.

Targeted Drug Delivery for Cancer

Lab21 – a new kind of company Antiviral drug discovery services and clinical trials support

Milestone in the development of Histone Deacetylase Inhibitors

Capravirine discontinued, but Pfizer's HIV R&D won't stop

The Pharmaceutical Market Outlook to 2015 Implementing innovative, long-term strategies for sustainable future growth

Olympus Europe and MMI Molecular Machines & Industries announce exclusive distribution agreement

BioInvent Interim Report 1 January-30 June 2005

Innate Pharma strengthens international management team by appointing Director of Business Development

Eden Biodesign and Partnership for Learning to champion

Inpharmatica launches Annotation Express(TM)

Cytheris launches two new Phase I clinical trials for its recombinant Interleukin-7

AnalytiCon Discovery To Identify New Natural Compounds For Johnson & Johnson Pharmaceutical Research & Development

Oxford Immunotec Prevails in Core Patent Dispute with Cellestis and Sanofi-Pasteur

Cytomics Systems identifies new anti-cancer molecules targeting the Ubiquitin-proteasome pathway

Daxas deal leaves Altana short of breath

Dow Pharmaceutical Sciences Announces FDA Approval of METROGEL® (metronidazole) Topical Gel 1% for Rosacea

Meditech Signs Collaboration Agreement with Hyalose

Acolyte to Provide Life Sciences Applications for Adenylate Kinase

Clinical trials catalyst for market shift

Wageningen research brings allergen-free apple within reach

‘Plants for the Future’ programme sets a European agenda for the goals and benefits of plant genomics and biotechnology

Danish biopharmaceutical company TopoTarget A/S successfully listed on Copenhagen Stock Exchange

Morphochem and The Genetics Company: successful resolution of X-ray structure of ß-secretase with a novel inhibitor compound

Key Organics Joins Proteom in Prolysis' Drug Discovery Program

Oxford Biomedica Is Granted Key Lentivector® Patents In China

Evolva and AnalytiCon enter Nuclear Receptor Alliance

Haptogen directors win science and technology prize at Scotland Entrepreneur of the Year Awards 2005

BioNewsCast Press Release Service 2005 Archive

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.